Read the Beforeitsnews.com story here. Advertise at Before It's News here.

By Renal Fellow Network (Reporter)
Contributor profile | More stories

Story Views
Now:
Last hour:
Last 24 hours:
Total:

Falsification Analysis

Sunday, January 20, 2013 19:50

% of readers think this story is Fact. Add your two cents.

Interesting paper this month in JAMA about post-marketing studies of adverse drug effects. Randomized controlled trials are obviously the gold standard for the detection of common adverse events related to treatment. The problem is that, if an adverse event is rare, it is unlikely to be detected by a normal RCT. As a result, there has been a move recently towards conducting post-marketing studies of commonly used drugs to identify rare adverse effects. One such effect mentioned in the study is the association between bisphosphonate use and atypical femoral fractures.

The other commonly cited example recently was the association between PPI use and community acquired pneumonia that has been noted in multiple studies. The putative mechanism is that it is due to a reduction in gastric pH. The problem is the question of residual confounding – is there an alternative reason that these patients have more pneumonia. Are these patients simply sicker overall? Are PCPs who prescribe PPIs more likely to diagnose pneumonia? Just because there is a plausible mechanism doesn’t make it true.

One potential solution is to perform a falsification analysis. Once you have determined the primary outcome of the study (in this case pneumonia) with a plausible outcome, you then perform a series of prespecified analyses with other non-plausible outcomes. If all of the outcomes are associated with the use of PPIs, it suggests that the association is more likely related to residual confounding rather than a real effect.

In the study referred to in the JAMA article, the authors, working from registry data, not only found an association between PPI use and pneumonia but also with osteoarthritis, urinary tract infections, rheumatoid arthritis, chest pain, DVTs and skin infections. Thus, they suggested that the association with pneumonia was more likely to be confounded because of the lack of a plausible relationship with these other adverse events. One criticism I would have is that I could think of perfectly reasonable hypotheses for why PPI use could be associated with OA and RA (use of NSAIDs) and chest pain (GERD). Another important point is that if this is not done properly (prespecified adverse events) you could find an association between the use of a drug an some adverse event if you tested enough and it could be used to wrongly refute the association between a drug and a problem.

Still, the whole article is a fascinating insight into the problems with post-marketing studies of drugs in the wider population.

2013-01-20 19:47:14

Source: http://renalfellow.blogspot.com/2013/01/falsification-analysis.html

Source:

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

LION'S MANE PRODUCT

Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules

Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.

Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

Comments

Visits:	1,708,856,888
Stories:	8,451,381